ACG Names Rajesh Bhogavalli Group Chief Commercial Officer

ACG, a Mumbai-based supplier of capsules, machinery, and packaging materials to pharmaceutical and nutraceutical manufacturers, has named Rajesh Bhogavalli as its new group chief commercial officer.¹

The move places a commercial and supply chain executive at the center of a company whose products touch a substantial share of global oral dosage production, making the appointment relevant to manufacturers who rely on ACG for capsules, equipment, or packaging.²

"We are delighted to welcome Rajesh to ACG," said Karan Singh, ACG’s managing director. "He brings a wealth of global experience, a strong track record in commercial strategy and operations, and a deep understanding of complex international businesses. His expertise will be invaluable as we continue to strengthen our operations and pursue the next phase of our growth strategy."

What Will ACG's New Chief Commercial Officer Be Responsible For?

In the newly created role, Bhogavalli will lead the company's global commercial strategy, oversee strategic partnerships, and direct cost-optimization initiatives alongside market expansion efforts. The position sits at the intersection of commercial strategy and operations, areas ACG has flagged as priorities as it works to scale its manufacturing footprint across various sectors, including nutraceuticals.

What Background Does Rajesh Bhogavalli Bring to the Role?

Bhogavalli joins ACG with more than 30 years of experience spanning commercial strategy, global supply chain management, and business transformation. He spent nearly 12 years at EPL Limited, formerly Essel Propack, most recently serving as president of supply chain and sustainability for the company's global operations across 11 countries.

Earlier in his career, he held senior leadership roles at BASF India and Asian Paints. He holds a master's degree in business administration in operations management from Indira Gandhi National Open University and a master's degree in physical chemistry from Andhra University.

"ACG has built an outstanding reputation across the pharmaceutical manufacturing ecosystem, and I'm excited to join the business at such an important stage of its growth," Bhogavalli said. "I look forward to further strengthening our commercial strategy, deepening customer relationships and supporting the company's continued global expansion."

Why Does This Appointment Matter to Nutraceutical Manufacturers?

ACG describes itself as the world's largest integrated supplier to solid dosage manufacturers, with operations spanning capsule production, processing and packaging machinery, barrier packaging materials, and track-and-trace systems across 138 countries.²

For manufacturers who depend on ACG as a supplier, changes in commercial leadership can signal shifts in how pricing, partnership terms, or capacity planning are approached going forward, particularly when a company frames the hire explicitly around cost optimization and market expansion.

What Comes Next for ACG's Global Growth Strategy?

ACG has not disclosed specific commercial targets, new markets, or timelines tied to Bhogavalli's appointment. The company describes the move as part of a broader continued investment in technologies and solutions supporting nutraceutical manufacturers worldwide, but has not released further details on what near-term changes, if any, manufacturers working with ACG should expect. Additional specifics about strategic priorities under the new commercial leadership were not available at the time of this appointment announcement.

References

1. ACG appoints Rajesh Bhogavalli as group chief commercial officer. ACG. Published August 14, 2026. Accessed August 17, 2026. Press release provided via email.

2. About ACG. ACG. Accessed August 17, 2026. https://www.acg-world.com/about-acg